Serialization plays an essential role in maintaining supply chain integrity, discouraging counterfeiting, and meeting regulatory requirements. In the United States, manufacturers are preparing for the Nov. 27, 2023 aggregation deadline to meet requirements of the Drug Supply Chain Security Act (DSCSA).

To read more, follow the link to the source.

Source: https://www.pharmtech.com/view/moving-forward-in-serialization